DrugPatentWatch Database Preview
CLINICAL TRIALS PROFILE FOR VICKS FORMULA 44
Clinical Trials for Vicks Formula 44
| Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
|---|---|---|---|---|---|---|
| NCT00000574 | Ibuprofen in Sepsis Study | Completed | National Heart, Lung, and Blood Institute (NHLBI) | Phase 3 | 1990-09-01 | To determine the effects of ibuprofen on mortality, development and reversal of shock, and adult respiratory distress syndrome, and on Lung Parenchymal Injury Score in adult patients with serious infection. |
| NCT00000574 | Ibuprofen in Sepsis Study | Completed | Vanderbilt University Medical Center | Phase 3 | 1990-09-01 | To determine the effects of ibuprofen on mortality, development and reversal of shock, and adult respiratory distress syndrome, and on Lung Parenchymal Injury Score in adult patients with serious infection. |
| NCT00000873 | A Study on the Effect of High-Calorie Infant Formula on Growth and Nutrition in HIV-Infected Infants | Completed | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | N/A | 1969-12-31 | This study examines the effects of an infant formula containing increased calories, as compared to commercial formulas, when given during the first 6 months of life. It will examine effects on growth, disease progress, immune system, and quality of life of infected infants. HIV disease in infants often leads to nutritional deficiencies. Providing increased nutrition early in their lives may help the quality of life of children who contract HIV from their mothers. |
| NCT00000873 | A Study on the Effect of High-Calorie Infant Formula on Growth and Nutrition in HIV-Infected Infants | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | N/A | 1969-12-31 | This study examines the effects of an infant formula containing increased calories, as compared to commercial formulas, when given during the first 6 months of life. It will examine effects on growth, disease progress, immune system, and quality of life of infected infants. HIV disease in infants often leads to nutritional deficiencies. Providing increased nutrition early in their lives may help the quality of life of children who contract HIV from their mothers. |
| >Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for Vicks Formula 44
Condition Name
Condition MeSH
Clinical Trial Locations for Vicks Formula 44
Trials by Country
Clinical Trial Progress for Vicks Formula 44
Clinical Trial Phase
Clinical Trial Status
Clinical Trial Sponsors for Vicks Formula 44
Sponsor Name
| Sponsor Name for Vicks Formula 44 | |
| Sponsor | Trials |
| Hoosier Cancer Research Network | 17 |
| National Institute of Allergy and Infectious Diseases (NIAID) | 11 |
| Shanghai University of Traditional Chinese Medicine | 9 |
| [disabled in preview] | 9 |
| This preview shows a limited data set Subscribe for full access, or try a Trial | |
Export unavailable in trial.
Subscribe for complete access.
